Hospital
Charleston Area Medical Center, INC.
Charleston Area Medical Center, INC. was paid $51.07M by Medicaid between Jan 2018 and Dec 2024, across 290 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 10% of everything it billed.
33Billing provider infoCHARLESTON AREA MEDICAL CENTER, INC.
CHARLESTON, WV 25301
CHARLESTON, WV 25301
33aNPI1124248752assigned 04/26/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$51.07M
24GClaims1,160,325
24DCodes billed290
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in West Virginia
Rank by total paid#5 of 26
Median peer was paid$18.33M
This provider vs. median2.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 123,013 | $6.85M | |
| 2019 | 69,463 | $2.96M | |
| 2020 | 138,839 | $5.95M | |
| 2021 | 158,661 | $5.20M | |
| 2022 | 215,583 | $9.04M | |
| 2023 | 253,901 | $11.83M | |
| 2024incomplete | 200,865 | $9.24M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 125,613 | 112,835 | $5.26M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 10% | 112,057 | 32,759 | $5.21M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.6% | 90,314 | 82,747 | $4.89M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.7% | 55,511 | 51,271 | $4.46M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.3% | 89,739 | 82,995 | $4.25M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.2% | 32,908 | 13,475 | $2.17M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.9% | 25,473 | 24,225 | $1.99M |
| 99223 | Prolong inpt eval add15 m | 3.6% | 18,711 | 14,676 | $1.85M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.4% | 56,617 | 52,867 | $1.73M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 3.2% | 12,227 | 5,420 | $1.63M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.6% | 25,297 | 24,006 | $1.33M |
| 99222 | Initial hospital care, per day, moderate complexity | 2.3% | 15,421 | 11,873 | $1.17M |
278 more codes
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.1% | 27,562 | $1.07M |
| 99285 | Emergency room visit (most serious) | 1.9% | 8,780 | $975K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.6% | 33,696 | $825K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.6% | 151,703 | $818K |
| 99215 | Doctor's office visit, returning patient (complex) | 1.4% | 8,944 | $706K |
| 99239 | Hospital discharge day management, more than 30 minutes | 1.4% | 10,863 | $698K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 4,421 | $447K |
| 99205 | Prolong outpt/office vis | <1% | 4,302 | $439K |
| 43282 | <1% | 491 | $421K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 7,759 | $359K |
| 88307 | <1% | 5,806 | $338K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 11,390 | $326K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 4,025 | $299K |
| 99221 | <1% | 5,377 | $288K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 11,622 | $272K |
| 93458 | <1% | 1,455 | $259K | |
| 00840 | <1% | 2,142 | $244K | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 337 | $215K |
| 00731 | <1% | 3,901 | $214K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 3,364 | $194K |
| 00790 | <1% | 1,345 | $171K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 4,389 | $168K |
| 88342 | <1% | 7,364 | $165K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 2,040 | $162K |
| 01961 | <1% | 1,496 | $146K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,709 | $146K |
| 00797 | <1% | 949 | $139K | |
| 47562 | <1% | 354 | $128K | |
| 93880 | <1% | 4,955 | $127K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 3,149 | $127K |
| 43775 | <1% | 356 | $127K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,277 | $120K |
| 93970 | <1% | 5,026 | $118K | |
| 99220 | <1% | 1,220 | $114K | |
| 95951 | <1% | 544 | $112K | |
| 90837 | Psychotherapy session, about an hour | <1% | 1,359 | $105K |
| 01922 | <1% | 1,041 | $90K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,629 | $88K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 731 | $82K |
| 75574 | <1% | 1,127 | $80K | |
| 20610 | <1% | 2,098 | $80K | |
| 59514 | <1% | 99 | $78K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 486 | $77K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 2,119 | $75K |
| 00400 | <1% | 1,039 | $71K | |
| 99217 | <1% | 1,825 | $70K | |
| 99219 | <1% | 939 | $69K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 849 | $65K |
| 31500 | <1% | 695 | $63K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,555 | $63K |
| 88341 | <1% | 3,774 | $62K | |
| 10060 | <1% | 865 | $54K | |
| 99460 | <1% | 934 | $54K | |
| 95886 | <1% | 1,018 | $53K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 476 | $51K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 400 | $50K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 3,476 | $50K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 420 | $45K |
| 99225 | <1% | 1,111 | $43K | |
| 59430 | <1% | 270 | $43K | |
| 93922 | <1% | 4,033 | $42K | |
| 95813 | <1% | 596 | $41K | |
| 00813 | <1% | 520 | $41K | |
| 88304 | <1% | 4,191 | $40K | |
| 99234 | <1% | 507 | $37K | |
| 95816 | <1% | 1,040 | $37K | |
| 00300 | <1% | 393 | $37K | |
| 93295 | <1% | 2,190 | $37K | |
| 36556 | <1% | 690 | $36K | |
| 93971 | <1% | 3,028 | $36K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 672 | $36K |
| 93016 | <1% | 2,053 | $34K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 438 | $34K |
| 99218 | <1% | 591 | $34K | |
| 93312 | <1% | 462 | $32K | |
| 00811 | <1% | 530 | $31K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,040 | $30K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,204 | $29K |
| 93925 | <1% | 1,210 | $29K | |
| 95720 | <1% | 190 | $28K | |
| 88187 | <1% | 1,317 | $28K | |
| 99442 | <1% | 4,793 | $27K | |
| 59025 | Fetal non-stress test | <1% | 1,537 | $27K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 123 | $27K |
| 92928 | <1% | 78 | $27K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,389 | $27K |
| 12001 | <1% | 922 | $27K | |
| 00920 | <1% | 382 | $26K | |
| 93018 | <1% | 2,022 | $25K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,395 | $25K |
| 76825 | <1% | 509 | $25K | |
| T2023 | Targeted case management; per month | <1% | 671 | $23K |
| 01480 | <1% | 263 | $23K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,257 | $22K |
| 81003 | <1% | 2,142 | $21K | |
| 00910 | <1% | 381 | $21K | |
| 85060 | <1% | 1,422 | $21K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 209 | $20K |
| 31575 | <1% | 460 | $20K | |
| 69210 | <1% | 729 | $19K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 280 | $18K |
| 00952 | <1% | 290 | $17K | |
| 99409 | <1% | 759 | $17K | |
| 43235 | <1% | 253 | $17K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 690 | $17K |
| 93298 | <1% | 1,049 | $17K | |
| 88173 | <1% | 368 | $16K | |
| 12011 | <1% | 425 | $16K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 273 | $15K |
| 52356 | <1% | 56 | $15K | |
| 64615 | <1% | 176 | $15K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 503 | $15K |
| 99443 | <1% | 1,305 | $15K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,079 | $15K |
| 93294 | <1% | 1,389 | $14K | |
| 81514 | <1% | 67 | $14K | |
| 12002 | <1% | 333 | $14K | |
| 99406 | <1% | 2,035 | $13K | |
| 88141 | <1% | 1,195 | $13K | |
| 01810 | <1% | 151 | $12K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,244 | $11K |
| 76830 | Ultrasound, transvaginal | <1% | 566 | $11K |
| 92133 | <1% | 835 | $11K | |
| 93978 | <1% | 521 | $11K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 392 | $11K |
| 93926 | <1% | 791 | $11K | |
| 97802 | <1% | 1,177 | $11K | |
| 99140 | <1% | 455 | $11K | |
| 94726 | <1% | 1,518 | $11K | |
| 99235 | <1% | 113 | $10K | |
| 88112 | <1% | 490 | $10K | |
| 99152 | <1% | 1,205 | $10K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 418 | $10K |
| 58571 | <1% | 15 | $9K | |
| 92083 | <1% | 511 | $9K | |
| 94729 | <1% | 1,668 | $9K | |
| 99226 | <1% | 159 | $9K | |
| 76827 | <1% | 513 | $9K | |
| 93308 | <1% | 543 | $9K | |
| 88311 | <1% | 1,096 | $8K | |
| 99462 | <1% | 307 | $8K | |
| 94010 | <1% | 1,546 | $8K | |
| 76820 | <1% | 550 | $8K | |
| 99441 | <1% | 1,746 | $8K | |
| 95819 | <1% | 162 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,014 | $7K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 113 | $7K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 256 | $7K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 256 | $7K |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | <1% | 25 | $7K |
| 31231 | <1% | 73 | $6K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 79 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 273 | $6K |
| 76937 | <1% | 760 | $6K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 443 | $6K |
| 93272 | <1% | 405 | $6K | |
| 44970 | <1% | 14 | $6K | |
| 99292 | <1% | 87 | $6K | |
| 99408 | <1% | 318 | $6K | |
| 93976 | <1% | 230 | $5K | |
| 93882 | <1% | 356 | $5K | |
| 92978 | <1% | 86 | $5K | |
| 95913 | <1% | 55 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 822 | $5K |
| 93660 | <1% | 75 | $5K | |
| 99224 | <1% | 202 | $5K | |
| 88302 | <1% | 1,077 | $5K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 128 | $4K |
| 80053 | Comprehensive metabolic panel | <1% | 672 | $4K |
| 29125 | <1% | 196 | $4K | |
| 94060 | <1% | 607 | $4K | |
| 73610 | <1% | 200 | $4K | |
| 00918 | <1% | 45 | $4K | |
| 88360 | <1% | 146 | $4K | |
| 73130 | <1% | 264 | $4K | |
| 87070 | <1% | 612 | $4K | |
| 95953 | <1% | 24 | $4K | |
| 54150 | <1% | 56 | $3K | |
| 73630 | <1% | 253 | $3K | |
| 93244 | <1% | 228 | $3K | |
| 92134 | <1% | 199 | $3K | |
| 52000 | <1% | 64 | $3K | |
| 88189 | <1% | 55 | $3K | |
| 95718 | <1% | 31 | $3K | |
| 93000 | <1% | 187 | $3K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,306 | $3K |
| 87186 | <1% | 395 | $3K | |
| 88312 | <1% | 152 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 279 | $2K |
| 90836 | <1% | 39 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 122 | $2K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 14 | $2K |
| 58300 | <1% | 64 | $2K | |
| 95811 | <1% | 27 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 446 | $2K |
| 93227 | <1% | 186 | $2K | |
| 73110 | <1% | 88 | $2K | |
| 36620 | <1% | 59 | $2K | |
| 80061 | Lipid panel | <1% | 216 | $2K |
| 76818 | <1% | 61 | $2K | |
| 00126 | <1% | 25 | $2K | |
| 73564 | <1% | 44 | $2K | |
| 10061 | <1% | 13 | $1K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 160 | $1K |
| 95911 | <1% | 17 | $1K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 704 | $1K |
| 52310 | <1% | 14 | $1K | |
| 92567 | <1% | 17 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 256 | $1K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 159 | $1K |
| 01830 | <1% | 14 | $1K | |
| 51798 | <1% | 86 | $1K | |
| 52332 | <1% | 12 | $1K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 28 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 16 | $1K |
| 95806 | <1% | 38 | $985.35 | |
| 62270 | <1% | 32 | $978.35 | |
| 93975 | <1% | 27 | $929.35 | |
| 88300 | <1% | 401 | $927.46 | |
| 81025 | <1% | 140 | $920.94 | |
| 96127 | <1% | 600 | $908.55 | |
| 93623 | <1% | 15 | $863.10 | |
| 00532 | <1% | 12 | $862.60 | |
| 85027 | <1% | 185 | $831.24 | |
| 99385 | <1% | 13 | $806.93 | |
| 88108 | <1% | 57 | $806.25 | |
| 01965 | <1% | 14 | $789.96 | |
| 00812 | <1% | 13 | $726.40 | |
| 90686 | <1% | 54 | $649.01 | |
| 95251 | <1% | 289 | $624.63 | |
| 73140 | <1% | 15 | $579.20 | |
| 87205 | <1% | 164 | $528.24 | |
| 88313 | <1% | 62 | $491.30 | |
| 27096 | <1% | 17 | $438.48 | |
| 93571 | <1% | 15 | $436.67 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 76 | $423.83 |
| 93228 | <1% | 43 | $394.65 | |
| 76801 | <1% | 12 | $372.68 | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | <1% | 169 | $361.62 |
| 93297 | <1% | 57 | $326.52 | |
| 99307 | <1% | 60 | $295.59 | |
| 75565 | <1% | 39 | $275.53 | |
| 87077 | <1% | 42 | $262.24 | |
| 80305 | <1% | 12 | $259.47 | |
| 78264 | <1% | 16 | $232.11 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 13 | $225.10 |
| 73030 | <1% | 13 | $219.96 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 30 | $208.10 |
| 90656 | <1% | 21 | $181.04 | |
| 3078F | <1% | 3,726 | $90.41 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 60 | $84.74 |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 12 | $66.26 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 107 | $65.56 |
| 93225 | <1% | 13 | $49.76 | |
| 3079F | <1% | 1,985 | $0.48 | |
| 3080F | <1% | 1,111 | $0.24 | |
| 3044F | <1% | 638 | $0.09 | |
| 3074F | <1% | 3,644 | $0.06 | |
| 3051F | <1% | 222 | $0.05 | |
| 3077F | <1% | 1,838 | $0.03 | |
| 3046F | <1% | 215 | $0.01 | |
| 3075F | <1% | 1,423 | $0.01 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 12 | $0.00 |
| 3725F | 0% | 15 | $0.00 | |
| 1159F | 0% | 13 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 293 | $0.00 |
| 1160F | 0% | 13 | $0.00 | |
| 99459 | 0% | 34 | $0.00 | |
| 3008F | 0% | 961 | $0.00 | |
| 1034F | 0% | 267 | $0.00 | |
| 3052F | 0% | 101 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 3,181 | $0.00 |
| 1036F | 0% | 639 | $0.00 | |
| 1111F | 0% | 1,227 | $0.00 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 2,062 | $0.00 |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 575 | $0.00 |
| 99024 | 0% | 13 | $0.00 | |
| 1035F | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBELL, STEPHEN (VP OF FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Charleston Area Medical Center, INC. | Ronceverte, WV | $1.42M |
| Stephen R Bell DO PC | Newport, MI | $36K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.